Comparison of "sandwich chemo-radiotherapy" and six cycles of chemotherapy followed by adjuvant radiotherapy in patients with stage IIIC endometrial cancer: A single center experience

Archives of Gynecology and Obstetrics

Volumn 288, Issue 4, 2013, Pages 845-850

  Dogan, Nasuh Utku ^a   Yavas, Guler ^a   Yavas, Cagdas ^b   Ata, Ozlem ^a   Yilmaz, Setenay Arzu ^a   Celik, Cetin ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b KONYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Acute toxicity; Endometrial cancer; Radiotherapy; Sandwich chemotherapy

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; ENDOMETRIUM CANCER; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; RETROSPECTIVE STUDY; SANDWICH CHEMORADIOTHERAPY; THERAPY DELAY; TREATMENT INDICATION; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; OVARIECTOMY; PACLITAXEL; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SALPINGECTOMY; TREATMENT OUTCOME;

EID: 84885376812     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2817-9     Document Type: Article

References (16)

1. Scribner DR Jr, Puls LE, Gold MA (2012) A phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus para aortic irradiation for stage III endometrial cancer. Gynecol Oncol (Epub ahead of print)
2. Ayhan A, Taskiran C, Celik C, Aksu T, Yuce K (2002) Surgical stage III endometrial cancer: analysis of treatment outcomes, prognostic factors and failure patterns. Eur J Gynaecol Oncol 23:553-556
3. Randall ME, Filiaci VL, Muss H et al (2006) Randomized phase III trial of whole abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 24:36-44
4. Randall ME, Filiaci VL, Muss H et al (2006) Randomized phase III trial of whole abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 24:36-44
5. Mundt AJ, McBride R, Rotmensch J et al (2001) Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 50:1145-1153
6. Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol 92:744-751
7. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC et al (2004) Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol 22:1234-1241
8. Alvarez Secord A, Havrilesky LJ, Bae-Jump V et al (2007) The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol 107:285-291
9. Duska LR, Berkowitz R, Matulonis U et al (2005) A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgrastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Gynecol Oncol 96:198-203
10. Gabriele A, Lissoni A, Cormio G et al (1998) Cisplatin, doxorubicin and cyclophosphamide (PAC) followed by radiation therapy in high-risk endometrial carcinoma. Int J Gynecol Cancer 8:397-402
11. Bruzzone M, Miglietta L, Franzone P et al (2004) Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients. Gynecol Oncol 93:345-352
12. Lupe K, Kwon J, D'Souza D et al (2007) Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach. Int J Radiat Oncol Biol Phys 67:110-116
13. Faught W, Fung MFK, Krepart GV, Lotocki RJ, Heywood MS, Genest P (1998) Microscopic surgical stage IIIc endometrioid adenocarcinoma of the endometrium: implications for bimodal adjuvant therapy. Int J Gynecol Cancer 8:41-45
14. Shah PH, Kudrimoti M, Feddock J, Randall M (2011) Adjuvant treatment for stage IIIC endometrial cancer: options and controversies. Gynecol Oncol 122:675-683
15. Geller MA, Ivy J, Dusenbery KE, Ghebre R, Isaksson Vogel R, Argenta PA (2010) A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the "sandwich" method for high risk endometrial carcinoma. Gynecol Oncol 118:19-23
16. Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A et al (2007) The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol 107:285-291